MRNA
Moderna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$226.89
+4.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 41.92x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 13.40x
- Price / sales
- 40.66x
- Price / cash flow
- -86.11x
Enterprise value
- Enterprise value
- $86.7B
- EV / sales
- 38.93x
- EV / EBITDA
- -30.66x
- EV / EBIT
- -26.12x
- Market cap
- $90.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026